Lycopene in combination with sorafenib additively inhibits tumor metastasis in mice xenografted with lewis lung carcinoma cells

HIGHLIGHTS

  • who: Nae-Cherng Yang from the Department of Science Biotechnology, National Chung Hsing University, Taichung, Taiwan, Department of have published the research work: Lycopene in Combination With Sorafenib Additively Inhibits Tumor Metastasis in Mice Xenografted With Lewis Lung Carcinoma Cells, in the Journal: (JOURNAL)
  • what: In this study, the effects of lycopene in combination with sorafenib to inhibit cancer metastasis in mice xenografted with the Lewis lung carcinoma (LLC) cells were investigated. Although it has been demonstrated that the ERK pathway is the main biological target of sorafenib, the results in this study demonstrate that . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?